שולי רווח נקי ממכירות: Palisade Bio (PALI)

Palisade Bio Inc. - לוגו גרפי של המנפיק PALI

Reviewing the sales margin levels on GURU.Markets, we observe that the indicator remains at -8739.20. The Palisade Bio, Inc. (PALI) business model is based on the full outsourcing of packaging and monitoring. Demand for gastrointestinal postoperative rehabilitation is independent of economic cycles. Meanwhile, the market valuation already prices in R&D costs, awaiting only future clinical trial data.

palisadebio.com (PALI) - רווחיות מכירות נקייה מ-04.07.2022 עד 19.11.2026

Palisade Bio (PALI) - פילוחי מדדים ודוחות פיננסיים

- שווי שוק ותחזית יעד של אנליסטים:
הערכת שווי פונדמנטלית:palisadebio.com - PALI
מוצרים מוגמרים של palisadebio.com

The development of the LB1148 protease inhibitor defines the financial profile of Palisade Bio, Inc. (PALI). The trend in average sales margins demonstrates the share of net profit in total revenue after deducting all operating and tax expenses. This proportion allows for the separation of speculative price growth from actual business efficiency. A decline in this metric amid rising share prices signals that the asset is overvalued, while a stable margin confirms the fundamental stability of the issuer.